RESEARCH VIA DAILY MARKET ANALYSIS ON EQUITY REPORT 14/03/2014

ECONOMY ANALYSIS
 Delhi HC upholds death sentence of Dec 16 gangrape convicts
 CBI carries out searches at NSEL office, 15 locations
 USFDA slaps import alert on Sun Pharma's Karkhadi plant
 Under-promising old Murthy trick; Infosys can surprise: Envision
 USFDA slaps import alert on Sun Pharma's Karkhadi plant
 Aim sales growth of over 10% for March quarter: V-Guard
 Lamborghini Huracan LP 610-4 to be launched in India

MARKET ANALYSIS
 MUMBAI: The BSE benchmark index Sensex today recovered by 29 points in a volatile trade on selective buying in pharma, FMCG and banking stocks even as global markets remained weak on concerns over China's growth.

 The 30-share index, which had lost 108.41 points in the previous session, rose by 29.80 points, or 0.14 per cent, to close at 21,856.22 points. It touched a day's low of 21,768.14 and a high of 21,965.95 points in a volatile trade.

 Sun PharmaBSE 4.08 %, which received US FDA approval for generic Temodar drug, was the biggest gainer among 30 Sensex scrips. It rose by 4.08 per cent.

 FMCG major ITCBSE 2.08 % rose by 2.08 per cent, Hero MotoCorpBSE 2.24 % by 2.16 per cent, TCSBSE 1.33 % by 1.33 per cent and WiproBSE 1.15 % by 1.15 per cent.

 Stocks of pharma and software industries were back in demand and recovered as rupee declined, brokers said.

0 comments:

Post a Comment